Overview

A Study Evaluating the Efficacy and Safety on Moderate to Severe Dry Eye

Status:
Completed
Trial end date:
2019-07-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of HBM9036 Ophthalmic Solution versus placebo in the treatment of dry eye
Phase:
Phase 2
Details
Lead Sponsor:
Harbour BioMed (Guangzhou) Co. Ltd.
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions